Phathom Pharmaceuticals Inc

NASDAQ:PHAT  
31.78
-1.28 (-3.87%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Phathom Pharmaceuticals Inc Stock, NASDAQ:PHAT

100 Campus Drive, Suite 102, Florham Park, New Jersey 07932
United States of America
Phone: +1.650.325.5156
Number of Employees: 55

Description

Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. Its product candidate vonoprazan is an oral small molecule potassium-competitive acid blocker. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.